Science Explorer Interactive view Map

Humanigen (United States)

Research works
21
▲ 2181% vs 2013–17
Citations
1.2k
56.0 per fractional work
Top-10% rate
6.1%
record average 16.5%
Open access
57%
world 28%

Not ranked overall: Humanigen (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Humanigen (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Genomic Integration, Embryonic Stem Cells, Pandemic, ACE2 Receptor, SARS-CoV-2, Gene Expression, Immunotherapy and Gene Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 24 words, with their numbers
  1. Genomic Integration2▲ 118×2 topics
  2. Embryonic Stem Cells2▲ 149×2 topics
  3. Pandemic2▲ 24×3 topics
  4. ACE2 Receptor2▲ 87×2 topics
  5. Gene Expression2▲ 16×3 topics
  6. SARS-CoV-22▲ 69×2 topics
  7. Immunotherapy2▲ 14×4 topics
  8. Epidemiology2▲ 2.2×4 topics
  9. Biopharmaceutical Production2▲ 103×2 topics
  10. Gene Therapy2▲ 32×3 topics
  11. Genetic Modification2▲ 199×1 topic
  12. Immune Response2▲ 12×3 topics
  13. Transgenic Animals2▲ 199×1 topic
  14. Cancer Immunotherapy1▲ 47×2 topics
  15. Genome Engineering1▲ 118×1 topic
  16. RNA-Guided1▲ 118×1 topic
  17. CAR T Cells1▲ 141×1 topic
  18. Chimeric Antigen Receptor1▲ 141×1 topic
  19. Tumor Regression1▲ 74×2 topics
  20. Clinical Characteristics1▲ 88×1 topic
  21. Thrombosis1▲ 27×1 topic
  22. Vaccine1▲ 14×3 topics
  23. Global Collaboration1▲ 119×1 topic
  24. Health Biotechnology1▲ 256×1 topic

Which research topics does Humanigen (United States) publish most on?

By volume in 2022–2025: COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Single-cell and spatial transcriptomics and Cancer Genomics and Diagnostics.

  1. 1 COVID-19 Clinical Research Studies Infectious Diseases 1 works
  2. 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  3. 3 Single-cell and spatial transcriptomics Molecular Biology 0 works
  4. 4 Cancer Genomics and Diagnostics Cancer Research 0 works
  5. 5 Cancer-related molecular mechanisms research Cancer Research 0 works
  6. 6 Long-Term Effects of COVID-19 Neurology 0 works
  7. 7 Sepsis Diagnosis and Treatment Epidemiology 0 works
  8. 8 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  9. 9 COVID-19 and healthcare impacts Oncology 0 works
  10. 10 CAR-T cell therapy research Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available57.4%not open42.6%

World: 28% of research is openly available.

with international co-authors23.8%domestic only76.2%

World: 19% is written across borders.

How has Humanigen (United States)'s research output changed?

Output in 2018–2022 was 2181% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Burlingame

All research institutions in Burlingame

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.